Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
about
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletionBrief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats.Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration.Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptorEcstasy: are animal data consistent between species and can they translate to humans?Developmental effects of 3,4-methylenedioxymethamphetamine: a review3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the ratA developmental comparison of the neurobehavioral effects of ecstasy (MDMA)MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus.Chronic corticotropin-releasing factor type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawn-Hooded rats.MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei.Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine.Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT.MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt.The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice.The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI).Central overexpression of angiotensin AT(1A) receptors prevents dopamine D(2) receptor regulation of alcohol consumption in mice.Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice.Impaired social behaviors and minimized oxytocin signaling of the adult mice deficient in the N-methyl-d-aspartate receptor GluN3A subunit.
P2860
Q24619949-5B5D82A1-F25D-4333-99BD-4AEB89075D52Q24648383-256766B8-436D-498F-8B40-445486615999Q28483841-AE5920B8-EF33-40BC-A55C-4EAC7853662CQ30481959-205DCE95-190E-48AE-A32D-53266DE11FFCQ30489879-64E8CC28-D324-468F-9DC1-4C97C210AD1FQ30544870-AA332CFA-2896-4F09-9BC2-CD9B97E799A9Q31033315-61518675-FCAD-4B38-B9E3-42BE30F28434Q33923930-AA06A33D-FD9E-4A8D-8B95-861CC357CEAAQ34565712-5BBB2BA2-9DF2-4683-9561-BDEB01CEAF95Q34645756-A94F5EDC-8E74-4B61-BDF5-345A2A6AF100Q35010538-92091BA1-8EBD-4B68-AF6F-84E231DADD49Q35142554-AF0725D5-A900-4605-B1F3-AC19702D576EQ35851128-65676309-9100-472F-8F2B-8A9AA8E50DC5Q37452207-7B780E8B-5F8B-4F48-AFB4-F5C87FBA2B20Q42348445-B8311559-2B20-43F0-9FC9-00A1BBF88507Q42480855-0BF3EA02-F3F6-4F99-9A5F-A49D25231A8DQ43729285-4D2453C6-F5F3-4DEE-B5B4-6834728619A4Q44255973-89591CA9-C7F0-4863-B87A-87F4AFA82219Q44662300-238D2AFC-9E65-4831-B3FB-994404DB6497Q44694966-4BF28AED-A0B7-4367-95FF-F75F8D2CCA1AQ44768744-94D73478-F358-41CF-BAA8-5C0D031E4681Q45331267-B679E983-5E38-45FB-A306-56602582CF96Q46533443-CD79E257-47D5-4E46-939B-935C72ABC7DBQ46658074-B6F0E152-B1E4-407A-A40D-5C2AA6A1F49EQ46970778-C6502A99-4DFF-4D6C-8DC1-EA9AC4CB8459Q47339519-53809DE3-F0E3-4B81-B22A-C88C8BFFC09FQ48193006-63982D4B-0D3B-420E-80CD-02D4C34AAD2CQ48273339-8C961B18-A628-470B-8EB1-F78142D8A64FQ52350440-43E5E816-6752-46DF-896B-B1E29589A16E
P2860
Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Increased anxiety 3 months aft ...... nsporter and receptor density.
@en
Increased anxiety 3 months after brief exposure to MDMA
@nl
type
label
Increased anxiety 3 months aft ...... nsporter and receptor density.
@en
Increased anxiety 3 months after brief exposure to MDMA
@nl
prefLabel
Increased anxiety 3 months aft ...... nsporter and receptor density.
@en
Increased anxiety 3 months after brief exposure to MDMA
@nl
P2093
P2860
P356
P1476
Increased anxiety 3 months aft ...... nsporter and receptor density.
@en
P2093
Andrew J Lawrence
Geoffrey Van der Plasse
Glenn E Hunt
Iain S McGregor
Kelly J Clemens
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300185
P407
P577
2003-04-16T00:00:00Z
P6179
1023663574